Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
10,000+ US Securities
Unlisted Companies not available on US Stock Exchanges
Professionally managed portfolios, designed by Vested’s research team
Get exposure to 50+ countries via global funds managed by the world’s top fund managers
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index (S&P TMI). more
| Time Frame | XPH | S&P500 |
|---|---|---|
| 1-Week Return | 6.09% | 3.24% |
| 1-Month Return | 9.13% | 4.53% |
| 3-Month Return | 4.94% | 3.48% |
| 6-Month Return | 22.97% | 5.58% |
| 1-Year Return | 54.27% | 33.26% |
| 3-Year Return | 40.15% | 69.58% |
| 5-Year Return | 22.48% | 68.93% |
| 10-Year Return | 36% | 235.97% |
| Time Frame | XPH | S&P500 |
|---|---|---|
| 1-Week Return | 2,081.42% | 427.32% |
| 1-Month Return | 189.50% | 71.43% |
| 3-Month Return | 21.60% | 14.88% |
| 6-Month Return | 52.09% | 11.64% |
| 1-Year Return | 54.27% | 33.26% |
| 3-Year Return | 11.91% | 19.25% |
| 5-Year Return | 4.14% | 11.06% |
| 10-Year Return | 3.12% | 12.88% |
| Stock name | Ticker | Weight |
|---|---|---|
Enliven Therapeutics Inc. | ELVN | 2.64% |
Organon & Co | OGN | 2.46% |
Corcept Therapeutics Incorporated | CORT | 2.34% |
Trevi Therapeutics Inc | TRVI | 2.13% |
Perrigo Company PLC | PRGO | 2.12% |
Axsome Therapeutics Inc | AXSM | 2.09% |
Terns Pharmaceuticals Inc | TERN | 2.04% |
MBX Biosciences, Inc. Common Stock | MBX | 2.02% |
Nektar Therapeutics | NKTR | 2.01% |
Jazz Pharmaceuticals PLC | JAZZ | 1.96% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
SPDR® S&P Pharmaceuticals ETF (XPH) share price today is $59.27.
Yes, Indians can buy shares of SPDR® S&P Pharmaceuticals ETF (XPH) on Vested. To buy XPH from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of SPDR® S&P Pharmaceuticals ETF (XPH) on Vested. You can start investing in SPDR® S&P Pharmaceuticals ETF (XPH) with a minimum investment of $1.
The 52-week high price of SPDR® S&P Pharmaceuticals ETF (XPH) is $58.77. The 52-week low price of SPDR® S&P Pharmaceuticals ETF (XPH) is $37.45.
The stock symbol (or ticker) of SPDR® S&P Pharmaceuticals ETF is XPH.
Yes, you can setup SIP in SPDR® S&P Pharmaceuticals ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of XPH on the Vested app.
The expense ratio of SPDR® S&P Pharmaceuticals ETF (XPH) is 0.35%.
Link copied